focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
There would be no reason to issue the TR-1 if Miton hadn't finished their selling.
Re this $2.75 million NIH grant to Imaging Biometrics and the Medical College of Wisconsin. Does anyone have details about the split between the two recipients? Is it 50%/50%? Can't seem to find the details anywhere.
Oh yes i does.
Well it annoyed the hell out of me because "completing its development" 3 weeks before Bleepa is launched is not what I want to read. I've worked in IT most of my working life and seeing that phrase so close to a product release is unnerving to say the least. Back in June / July they were beta testing the product in Poland and I'd have hoped all major bugs were out of the system by the end of testing. Only minor, within latest specification stuff should be remaining at that point. That "completing its development " phrase was akin to shooting oneself in the foot and I was angry at seeing it because it contradicted the beta testing in Poland results I'd heard about.
Now, I really don't know whether to blame Andrew Scott or Tom Oakley for it. I can only say that for me it I now have a concern about the product that I didn't have yesterday. They will be complete bâtards if they mess things up at this late stage. The next 3 weeks will have me on tenterhooks.
Here it is. Written by Andrew Scott, the man who interviewed Tom Oakley. Tom either said it to Andrew off camera or he made it up.
"He also touches on the recent well-supported £2mln fundraise which he says will be used for completing its development and building up a sales and support team for when the product is launched next month at NHS Expo in Manchester."
Full article follows.
https://www.proactiveinvestors.co.uk/companies/news/900861/feedback-plc-gearing-up-for-big-launch-of-its-clinical-messaging-product-bleepa-900861.html
Agree with you Chaz. You don't say "the recent well-supported £2mln fundraise... will be used for completing its development" 3 weeks before Bleepa is shown to the public. It should not be completing development at this point. It should have been written with no further changes allowed and that version thoroughly tested by now. FFS they should not be talking about "completing its development". They should be practicing their speech writing and sales pitch from this point onwards.
https://twitter.com/AndrewScottTV/status/1161976815742836737
Simon Eccles - Chief Clinical Information Officer for Health and Care. Deputy CEO NHSX.
https://twitter.com/BleepaMe/status/1160458284496760832
WhatsApp Doc? New device answers SOS.
https://www.businessweekly.co.uk/news/biomedtech/whatsapp-doc-new-device-answers-sos